Welcome to our dedicated page for SHERWIN WILLIAMS CO SEC filings (Ticker: SHW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on SHERWIN WILLIAMS CO's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into SHERWIN WILLIAMS CO's regulatory disclosures and financial reporting.
SHERWIN WILLIAMS CO (SHW) executive Justin T. Binns, President, Glob. Architectural, reported multiple transactions in Sherwin-Williams common stock. On August 17, 2026, he exercised 13,500 stock options with a $90.04 exercise price, receiving an equal number of common shares, and on the same date sold 13,500 shares at a weighted average price of about $352.70 per share in multiple trades between $353.01 and $352.66.
On August 18, 2026, he made a bona fide gift of 813 shares to a charitable donor advised fund. Following these transactions, 6,009.63 shares of common stock are attributable to his participation in The Sherwin-Williams Company 401(k) Plan, reported as indirect ownership. The exercised options, granted in 2016, are now fully exhausted according to this report.
Sherwin-Williams Company officer Karl J. Jorgenrud, President, Global Industrial, reported several equity transactions on 2026-08-07. He exercised 90 stock options at an exercise price of $127.98 per share, receiving 90 shares of common stock. On the same date, he sold 7,886 shares of Sherwin-Williams common stock at $368.30 per share in a sale transaction. Following the option exercise, he held 4,260 employee stock options directly, expiring 2027-10-17, and had 1,252.54 shares of common stock attributable to his participation in The Sherwin-Williams Company 401(k) Plan as of 2026-06-30. The transactions are not indicated as being made pursuant to a Rule 10b5-1 trading plan.
A shareholder of Sherwin-Williams (SHW) filed to sell up to 7,886 shares of common stock through Fidelity Brokerage Services LLC on August 7, 2026 on the NYSE. The filing lists an aggregate market value of approximately $2,904,413.80 for the planned sale.
The shares derive from restricted stock vesting awards, including 2,665 shares vesting on February 13, 2026 and 5,221 shares vesting on February 17, 2026, both described as compensation from the issuer.
The Sherwin-Williams Company reported higher results for the quarter and six months ended June 30, 2026. Consolidated net sales rose 7.5% in the quarter to $6,789.3 million and 7.2% year to date to $12,456.2 million, with growth in all three segments and contributions from the 2025 Suvinil acquisition. Management reports diluted EPS increased 14.3% to $3.43, with adjusted diluted EPS up to $3.70; for the first half, diluted EPS was $5.58 and adjusted diluted EPS $6.05. Net income for the quarter was $843.6 million.
Gross margin remained around 49% despite moderately higher raw material costs and the dilutive impact of Suvinil, while SG&A stayed roughly stable as a percentage of sales. Net operating cash flow improved to $1,486.6 million in the first six months versus $1,051.5 million a year earlier. At June 30, 2026, total assets were $26,951.4 million and total debt $12,072.1 million, with cash and equivalents of $293.5 million and $1.969 billion of unused credit capacity. The company repurchased 5.6 million shares for $1,837.0 million year to date and paid dividends of $1.60 per share.
The Sherwin-Williams Company reported strong second-quarter 2026 results, with consolidated Net sales of $6.79 billion, up 7.5% year over year. Net income was $843.6 million (12.4% of Net sales), and diluted EPS rose 14.3% to $3.43; adjusted diluted EPS was $3.70, up 9.5%.
EBITDA reached $1.43 billion, or 21.1% of Net sales, and Adjusted EBITDA increased 13.8%. Net operating cash improved 21%, free cash flow conversion was 86%, and the company returned $2.23 billion to shareholders in the first half, including dividends and repurchases of 5.6 million shares.
By segment, Paint Stores Group Net sales were $3.89 billion, up 5.1% with same-store sales up 4.2%; Consumer Brands Group grew 21.5% to $983.5 million aided by the Suvinil acquisition; Performance Coatings Group rose 6.3% to $1.91 billion.
Sherwin-Williams raised full-year 2026 guidance, now expecting consolidated Net sales up a mid to high-single digit percentage and diluted EPS of $10.92–$11.32 (adjusted $11.80–$12.20). Management cited cost inflation and announced an 8% Paint Stores Group price increase effective September 1 and restructuring actions targeting about $17 million of annual savings.
Sherwin-Williams director Thomas Williams reported a compensation-related equity award rather than an open-market trade. He acquired 96.32 deferred stock units of common stock at a weighted average reference price of $350.40 per unit under the 2005 Director Deferred Fee Plan, in an exempt transaction. These units are economically equivalent to common shares and will generally be paid in stock after he leaves the board.
Following this award, Williams now indirectly holds 1,262.09 deferred stock units under the Deferred Fee Plan. Separately, he directly holds 2,371 common-stock-related interests, consisting of 1,334 restricted stock units and 1,037 shares of common stock, reflecting his ongoing equity-based stake in the company.
The Sherwin-Williams Company director Michael H. Thaman acquired 96.32 deferred stock units of common stock on July 6, 2026 at a weighted average price of $350.40 per share under the 2005 Director Deferred Fee Plan. Each deferred stock unit is the economic equivalent of one share of common stock and will be paid solely in stock, generally after he leaves the board. Following this grant, he holds 5,712.57 deferred stock units indirectly through the plan and 8,111 equity interests directly, consisting of 1,100 restricted stock units and 7,011 shares of common stock.
Sherwin-Williams director Robert James Gamgort reported a compensation-related stock award. He acquired 96.32 deferred stock units of common stock on July 6, 2026 in an exempt transaction under the company’s 2005 Director Deferred Fee Plan, at a weighted average price of $350.40 per unit.
Each deferred stock unit is economically equivalent to one share of common stock and will be settled in stock, generally after he leaves the board. Following this award, his Deferred Fee Plan account holds 585.55 deferred stock units held indirectly, while a separate line reflects 1,075 directly held shares previously reported.
Sherwin-Williams director Kerrii B. Anderson received an award of deferred stock units under the company’s 2005 Director Deferred Fee Plan. She acquired 28.54 deferred stock units, each economically equivalent to one share of common stock, based on a weighted average share price of $350.40.
These units are held indirectly through the Deferred Fee Plan and become payable in stock, generally after she leaves the board. Following this award, she holds 1,076.42 deferred stock units under the plan, and separately has 5,819 direct equity interests, consisting of 1,100 restricted stock units and 4,719 common shares.